Safety and Efficacy of Nivolumab + Ipilimumab in Patients With Melanoma and Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Safety and Efficacy of the Combination of Nivolumab Plus Ipilimumab in Patients With Melanoma and Asymptomatic or Symptomatic Brain Metastases (CheckMate 204)
Neuro-oncology 2021 Apr 21;[EPub Ahead of Print], HA Tawbi, PA Forsyth, FS Hodi, CD Lao, SJ Moschos, O Hamid, MB Atkins, K Lewis, RP Thomas, JA Glaspy, S Jang, AP Algazi, NI Khushalani, MA Postow, AC Pavlick, MS Ernstoff, DA Reardon, I Puzanov, RR Kudchadkar, AA Tarhini, A Sumbul, JI Rizzo, KA MargolinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.